Literature DB >> 21940550

MRI features of inflammatory breast cancer.

Huong T Le-Petross1, Massimo Cristofanilli, Selin Carkaci, Savitri Krishnamurthy, Edward F Jackson, Robyn K Harrell, Brandy J Reed, Wei T Yang.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the features of inflammatory breast carcinoma (IBC) on MRI compared with mammography and ultrasound and to better define the role of MRI in patients with this aggressive disease.
MATERIALS AND METHODS: A retrospective analysis was performed of patients with newly diagnosed IBC evaluated at a single institution between 2003 and 2008. Baseline MRI examinations were performed on a 1.5- or 3-T scanner using contrast-enhanced 3D T1-weighted gradient-echo sequences with parallel imaging. MRI findings were rated in accordance with the BI-RADS MRI lexicon established by the American College of Radiology. All patients underwent concomitant mammography and ultrasound examinations.
RESULTS: Eighty women with a clinical diagnosis of IBC were included in the study (median age, 52 years; age range, 25-78 years). MRI detected a primary breast lesion in 78 of 80 symptomatic breasts (98%) compared with 53 of 78 (68%) with mammography (p < 0.0001) and 75 of 80 (94%) with ultrasound. Of the 78 breasts with a primary lesion, the most common MRI finding was a mass or multiple masses (57/78, 73%). Masses were frequently multiple, small, and confluent (47/57, 82%); mass margins, irregular (43/57, 75%); and internal enhancement pattern, heterogeneous (47/57, 82%). Kinetic analysis revealed a delayed washout pattern in 66 of 78 tumors (85%). MRI showed skin thickening in 74 of 80 breasts (93%), whereas mammography showed skin thickening in 56 of 78 breasts (72%).
CONCLUSION: Multiple small, confluent, heterogeneously enhancing masses and global skin thickening are key MRI features of IBC that contribute to improved detection of a primary breast cancer and delineation of disease extent compared with mammography.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940550     DOI: 10.2214/AJR.10.6157

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

1.  The use of ultrasonography and digital mammography in women under 40 years with symptomatic breast cancer: a 7-year Irish experience.

Authors:  C E Redmond; G M Healy; C F Murphy; A O'Doherty; A Foster
Journal:  Ir J Med Sci       Date:  2016-06-07       Impact factor: 1.568

2.  An unexpected diagnosis of breast malignancy.

Authors:  T Richardson; F Cottier
Journal:  Ann R Coll Surg Engl       Date:  2017-07       Impact factor: 1.891

3.  Inflammatory breast carcinoma.

Authors:  Kelli Y Ha; Shannon B Glass; Louba Laurie
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

4.  Fat suppression strategies in MR imaging of breast cancer at 3.0 T: comparison of the two-point Dixon technique and the frequency selective inversion method.

Authors:  Wakako Kaneko Mikami; Toshiki Kazama; Hirotaka Sato; Hajime Yokota; Takashi Higashide; Takuro Horikoshi; Ken Motoori; Yukimasa Miyazawa; Takeshi Nagashima; Takashi Uno
Journal:  Jpn J Radiol       Date:  2013-06-24       Impact factor: 2.374

5.  ¹⁸F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer.

Authors:  Laurence Champion; Florence Lerebours; Pascal Cherel; Veronique Edeline; Anne-Laure Giraudet; Myriam Wartski; Dominique Bellet; Jean-Louis Alberini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-03       Impact factor: 9.236

Review 6.  Magnetic resonance imaging in the evaluation of pathologic nipple discharge: indications and imaging findings.

Authors:  Naziya Samreen; Laura B Madsen; Celin Chacko; Samantha L Heller
Journal:  Br J Radiol       Date:  2021-02-05       Impact factor: 3.039

7.  Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research.

Authors:  D Rea; A Francis; A M Hanby; V Speirs; E Rakha; A Shaaban; S Chan; S Vinnicombe; I O Ellis; S G Martin; L J Jones; F Berditchevski
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

8.  Delayed presentation of inflammatory breast carcinoma during the COVID-19 pandemic.

Authors:  Daniele Bernardi; Emanuele Asti; Giulia Bonavina; Alberto Luporini; Claudio Clemente; Luigi Bonavina
Journal:  Eur Surg       Date:  2021-06-15       Impact factor: 0.796

9.  The Third International Inflammatory Breast Cancer Conference.

Authors:  Kenneth L van Golen; Massimo Cristofanilli
Journal:  Breast Cancer Res       Date:  2013-11-05       Impact factor: 6.466

10.  Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms.

Authors:  Yohann Dabi; Lauren Darrigues; Kelly Pons; Mylène Mabille; Issam Abd Alsamad; Rana Mitri; Dounia Skalli; Bassam Haddad; Cyril Touboul
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.